Almirall pulling Constella in Germany

Almirall S.A. (Madrid:ALM) said it will no longer market Constella linaclotide in Germany after failing to agree on a price with Germany's Statutory Health Insurance Funds Association (GKV-Spitzenverband). In October, Germany's Federal Joint Committee (G-BA) said the guanylate cyclase C ( GCC; GUCY2C) agonist has "no additional benefit" for irritable bowel syndrome with constipation (IBS-C) vs. a change in diet and symptom-specific treatment (see BioCentury Extra, Oct. 17, 2013). ...